Omron Healthcare India profits to surpass USD 21.93 million in FY21
Category: #health  | By Nikita Chaurasia  | Date: 2020-09-08 |
  • shareshare_icon
  • Twitter
  • Facebook
  • LinkedIn

Omron Healthcare India profits to surpass USD 21.93 million in FY21

 

  • Omron aims to record 27% spike in revenues by FY21
  • The revenue growth is attributed to rising cognizance regarding home monitoring systems

Omron Healthcare India, a leading medical devices manufacturer, is reportedly planning to generate revenues worth USD 21.93 million by the year 2021. Sources with relevant information stated that the upsurge in revenues is primarily attributed to the increasing consumer awareness pertaining to home monitoring following the COVID-19 pandemic.

It is to be noted that Omron Healthcare had initially reached a valuation of USD 16 million in 2020. The company claims to witness a 27% increase in revenues during the current financial year, sources claimed.

It appears that the enhancement in organization’s revenues is triggered by the rising cognizance about monitoring and managing respiratory ailments and blood pressure at home. The company has reportedly witnessed an 30% upsurge in sales of blood pressure monitoring systems post the virus outbreak

In this context, Masanori Matsubara, Managing Director of Omron Healthcare India, mentioned that the emergence of COVID-19 pandemic has compelled people to not only be careful, but also adopt preventive healthcare practices. He added that the coronavirus outbreak has forced people to find virtual or remote methods for optimal health management.

Matsubara further claimed that widespread adoption of teleconsultation and telemedicine services has impelled the demand for home monitoring devices such as drug administrating devices, infra-red and digital thermometers, and digital blood pressure monitors.

If sources are to be believed, Omron Healthcare is planning to create awareness regarding hypertension management in tier 2 and tier 4 cities. Another focus area for the company is the rural population which suffers from similar ailments, cited sources close to the company.

In other news, Omron Healthcare lately entered the telemedicine segment by partnering with AI-based healthcare management company PhableCare and introduced India’s first end-to-end virtual hypertension management service at home.

Source Credits –

https://medicaldialogues.in/news/omron-healthcare-india-aims-at-rs-150-cr-revenue-in-fy21-69312

  • shareshare_icon
  • Twitter
  • Facebook
  • LinkedIn


About Author

Nikita Chaurasia     twitter

Nikita Chaurasia

Having always been daft at wordplay, Nikita Chaurasia, post the completion of post-graduation, commenced her journey into the content generation cosmos. Endowed with a professional MBA degree in Advertising and Public Relations, Nikita strives to integrate her creativ...

Read More..

More News By Nikita Chaurasia

Dr. Reddy’s becomes India’s second biggest drugmaker by sales

Dr. Reddy’s becomes India’s second biggest drugmaker by sales

By Nikita Chaurasia

Dr. Reddy's Laboratories Ltd. and Cipla Ltd. surpassed Aurobindo Pharma to rank as the 2nd and 3rd largest drug manufacturers in India by sales in the three months that ended on September 30. This was the first change in the pecking order of the ...

UK’s business confidence drops to its lowest point since 2009

UK’s business confidence drops to its lowest point since 2009

By Nikita Chaurasia

According to recent data, business confidence in the UK dropped to 18% in October, which was its lowest level in at least 13 years. In contrast, however, net balances of confidence stood at 28% in June and 56% in February, according to Accenture and ...

Attero aims to increase recycling capacity, plans for IPO in 2025

Attero aims to increase recycling capacity, plans for IPO in 2025

By Nikita Chaurasia

Attero Recycling, a firm that recycles electronic waste, is aiming to launch an initial public offering (IPO) in 2025, according to its Co-Founder and CEO Nitin Gupta. As per Gupta, the company is currently debating whether to list its shares in I...